Patent extenders stretch drugmakers' bottom lines Sep 10, 2006
...of Abbott Laboratories' Biaxin known as clarithromycin came on the market last year, the twice-a-day copy has eaten into once-a-day Biaxin XL, which was ... -Chicago Tribune
Abbott Labs, Teva Pharma Settle Biaxin XL Patent Dispute Aug 1, 2006
Abbott Laboratories (ABT) said Tuesday that Teva Pharmaceuticals Industries (TEVA) agreed to settle a patent lawsuit involving Abbott's antibiotic Biaxin XL. ... -Easy Bourse (Communiqués de presse)
ABBOTT LABORATORIES: Reaches settlement over Biaxin lawsuit Aug 2, 2006
...the world's biggest generic-drug company, and North Chicago-based Abbott Laboratories agreed to settle a patent lawsuit over the antibiotic Biaxin XL on Tuesday ... -Chicago Tribune
Teva to stop sales of generic Biaxin XL Jun 27, 2006
...(ABT.N: Quote, Profile, Research) had filed an emergency motion in US federal court to try to block sales of a generic version of Abbott's Biaxin XL. ... -Reuters
Teva Provides Generic Biaxin XL Update Jun 27, 2006
JERUSALEM--(BUSINESS WIRE)--Jun 27, 2006 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it launched Teva's ... -PharmaLive.com
Teva halts sales of generic antibiotic Jun 27, 2006
Drugmaker stops sales of Biaxin XL until court rules on patent protection of Abbott drug. Teva halts sales of antibiotic pending ... -CNNMoney.com
Teva pulls generic Biaxin after Abbott files lawsuit Jun 28, 2006
Teva launched a generic version of Abbott's Biaxin XL product last Friday, after a federal court of appeal overturned a preliminary injunction blocking its ... -Pharma Times (subscription)
Teva halts sales of antibiotic pending hearing Jun 27, 2006
Teva said it agreed to stop selling its version of the extended release antibiotic Biaxin XL pending outcome of a hearing set for Thursday before the judge who ... -MSN Money
Preliminary ban voided on generic Biaxin Jun 23, 2006
...maker Teva Pharmaceuticals Industries Ltd. from launching unauthorized copies of Abbott Laboratories' Biaxin XL. The US Court of ... -Chicago Tribune
Teva Launches Generic Biaxin; To Refrain From Sales Pending ... Jun 27, 2006
...product. Teva is currently involved in patent litigation with Abbott over Biaxin XL Filmtabs, with a trial scheduled for March 2007. ... -Trading Markets
Teva Agrees To Refrain From Further Sales Of Generic Biaxin XL ... Jun 27, 2006
...(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA | charts | news | PowerRating) said Tuesday that it launched Teva's generic Biaxin XL Filmtabs last ... -Trading Markets
UPDATE - Teva Pharmaceutical (TEVA) Issues Press Release Regarding ... Jun 22, 2006
...for the Northern District of Illinois, which had granted Abbott's (NYSE: ABT) motion for a preliminary injunction related to Teva's generic Biaxin XL Filmtabs. ... -StreetInsider.com (subscription)
Teva Pharma Says US Appeal Court Vacates Injection Barring Sale Of ... Jun 22, 2006
The Petach Tikva, Israel based Teva noted that it is currently involved in patent litigation with Abbott concerning Biaxin XL Filmtabs. ... -Trading Markets
Teva Pharma Says Court Of Appeals Rules In Favor Of Company On ... Jun 22, 2006
...ruling from the US Court of Appeals for the Federal Circuit regarding Abbott's motion for a preliminary injunction related to Teva's generic Biaxin XL Filmtabs ... -Trading Markets
Abbott Moves to Block Biaxin Sales Jun 27, 2006
...pharmaceutical company, said Tuesday that Abbott Laboratories filed an emergency motion to stop Teva from further sales of its generic Biaxin XL Filmtabs. ... -TheStreet.com
US court lifts injunction in Abbott's Biaxin patent case Jun 22, 2006
Abbott's patent for Biaxin XL extends until 2017, and the company is also in court with several other generic drugmakers over the patent. ... -Crain's Chicago Business
Teva Says Court Rules In Its Favor In Biaxin Injunction Jun 22, 2006
...district court ruling which had granted Abbott Laboratories' (ABT) motion for a preliminary injunction related to Teva's generic version of Biaxin XL filmtabs. ... -Therapeutics Daily (subscription)
Teva agrees temporary halt of generic antibiotic sale after Abbott ... Jun 27, 2006
Abbott's motion for a preliminary injunction related to Teva's drug, which is the generic equivalent of Abbott's Biaxin XL Filmtabs. ... -Forbes
Appeals Court Vacates Teva Injunction Jun 22, 2006
Laboratories a preliminary injunction against Teva's Clarithromycin Extended Release Tablets, which are a generic equivalent of Abbott's Biaxin XL Filmtabs. ... -Houston Chronicle
Court of Appeals Rules in Favor of Teva on Biaxin XL Preliminary ... Jun 23, 2006
JERUSALEM--(BUSINESS WIRE)--Jun 22, 2006 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the United States ... -PharmaLive.com
Abbott Reports First Quarter Results Led by Strong Medical ... Apr 19, 2006
...season. As a reminder, we continue to promote the once-daily formulation, Biaxin XL, which is not subject to generic competition. ... - PR Newswire
Report any muscle issues while using statin drugs Mar 27, 2006
Q: An ENT doctor prescribed an antibiotic called Biaxin XL. ... A: Biaxin "XL" is an extended-release form of Biaxin (clarithromycin). ... - Contra Costa Times
Andrx Corporation Reports Financial Results for 2005 Fourth ... Mar 16, 2006
...to cost of goods sold of $6.1 million related to pre-launch inventories, including $5.6 million related to our generic version of Biaxin XL in connection with ... - Business Wire
UPDATE 1-Andrx posts lower quarterly earnings as revs fall Mar 16, 2006
...(ABT.N: Quote, Profile, Research) prevented Andrx's planned fourth-quarter launch of a generic version of Biaxin XL antibiotic, resulting in a $5.6 million ... - Reuters
Andrx Q4 Net Income More Than Halves -update Mar 16, 2006
...news | Powerrating) was granted a preliminary injunction pending a trial on the merits related to our FDA-approved generic version of Biaxin XL, which resulted ... - Trading Markets
Earnings decline at Andrx for Q4, year Mar 18, 2006
The most recent quarter included a $5.6 million charge on inventory because Andrx has not yet been able to launch its regulator-approved generic for Biaxin XL. ... - Bizjournals.com
Andrx 4Q profit slides 60 percent Mar 16, 2006
The quarter was hurt by a $5.6 million inventory charge due to the delayed launch of Andrx's generic version of the antibiotic Biaxin XL. ... - BusinessWeek